The European Association for Cardio-Thoracic Surgery (EACTS) formally withdrew its support for the latest coronary revascularization guidelines following a BBC investigation suggesting that data from the EXCEL trial might have been manipulated. The recommendations for left main coronary artery revascularization featured in the 2018 guidelines, which were written jointly with the European Society of Cardiology<a href="https://solaci.org/en/2020/01/06/latest-guidelines-dropped-after-scandal-over-excel-results/" title="Read more" >...</a>
Secondary Prevention: A Responsibility We Should Not Delegate
After coronary angioplasty, the use of drugs whose efficacy for the reduction of major events has been proven declines over time, which is associated with worse patient prognosis. Sometimes, without meaning to, we convey to patients the idea that, once the stent has been implanted, the artery is “cured” or that the only potential future<a href="https://solaci.org/en/2019/12/26/secondary-prevention-a-responsibility-we-should-not-delegate/" title="Read more" >...</a>
Survey on Peripheral Interventions: Your Feedback Will Help Us Grow!
The Latin American Society of Interventional Cardiology (SOLACI) is conducting a survey about peripheral endovascular interventions that is aimed at interventional cardiologists. We would appreciate it if you could answer this brief questionnaire. It consists of only 14 questions. It should take you less than five minutes. We appreciate your time and disposition to answer these<a href="https://solaci.org/en/2019/11/28/survey-on-peripheral-interventions-your-feedback-will-help-us-grow/" title="Read more" >...</a>
Regional Course of Interventionism for the Clinical Cardiologist | with SOLACI’s Support
On November 30, 2019, the “I Regional Course of Interventionism for the Clinical Cardiologist” will take place in Chiclayo, Peru. The event will be held in the Muchick Room at Costa del Sol Hotel, organized by the Peruvian Society of Hemodynamics and Endovascular Interventionism (SOPHIE) with the support of SOLACI. The activity will be oriented to<a href="https://solaci.org/en/2019/11/13/regional-course-of-interventionism-for-the-clinical-cardiologist-with-solacis-support/" title="Read more" >...</a>
1000 MitraClips: Results from the World’s Most Experienced Site
In September 2008, interventional physicians at the Heart and Vascular Centre Hamburg conducted the first MitraClip implantation after its Conformité Européenne (CE)-marking approval. In July 2019, the same site reached an amazing milestone, 1000 MitraClips implanted, and in doing so it became the most experienced site in the world. Those 1000 patients treated had an average logistic<a href="https://solaci.org/en/2019/10/28/1000-mitraclips-results-from-the-worlds-most-experienced-site/" title="Read more" >...</a>
SOLACI Interviews | Dr. Carla Agatiello: “The aim of Grupo MIL is to create a collaboration network of women across Latin America”
The predominance of women in the world is an uncontested reality that is causing changes in different aspects of daily life. In the world of interventional cardiology, the number of women compared to men has always been very low. However, this process is slowly beginning to change because more and more women are showing their<a href="https://solaci.org/en/2019/10/23/solaci-interviews-dr-carla-agatiello-the-aim-of-grupo-mil-is-to-create-a-collaboration-network-of-women-across-latin-america/" title="Read more" >...</a>
The Most Read Scientific Articles in September at Solaci.org
1- ESC 2019 | New European Guidelines on “Chronic Coronary Syndromes” In Paris, during the European Society of Cardiology (ESC) Congress 2019 Scientific Sessions, new guidelines for the diagnosis and treatment of chronic coronary syndromes were presented. This document, simultaneously published in Euro Heart J, updates the 2013 guidelines on stable ischemic heart disease and<a href="https://solaci.org/en/2019/10/21/the-most-read-scientific-articles-in-september-at-solaci-org/" title="Read more" >...</a>
TCT 2019 | PARTNER 2A at 5 Years: In Intermediate-Risk Patients, TAVR Is Still Head-to-Head with Surgery
Courtesy of the SBHCI. The 2-year results of the PARTNER 2A trial showed that transcatheter aortic valve implantation has a result similar to that of surgery in patients with aortic stenosis and intermediate surgical risk. We lacked long-term data, both clinical and related to prosthesis function. Now, at TCT 2019, researchers presented the 5-year data for this<a href="https://solaci.org/en/2019/10/01/tct-2019-partner-2a-at-5-years-in-intermediate-risk-patients-tavr-is-still-head-to-head-with-surgery/" title="Read more" >...</a>
TAVR and Pacemakers, New Strategies
Courtesy of Dr. Carlos Fava. TAVR has been shown beneficial and is constantly being advanced onto lower risk populations, but at present, it is limited (perhaps most importantly in aortic tricuspid valves) by the need for permanent pacemaker implantation (PPMI), especially when it comes to self-expandable valves, as the latest study on low risk populations<a href="https://solaci.org/en/2019/09/30/tavr-and-pacemakers-new-strategies/" title="Read more" >...</a>
Dr. Gustavo Vignolo: “The Sessions Are a Significant Support Base for SOLACI”
Given the upcoming Panama and Ecuador 2019 Sessions, solaci.org interviewed Dr. Gustavo Vignolo (Sessions Assistant Director) and asked him about his vision for Latin American interventional cardiology and the importance of a project such as the Sessions to help this specialty reach all corners of our continent. — How is, in your experience, the current<a href="https://solaci.org/en/2019/09/18/dr-gustavo-vignolo-the-sessions-are-a-significant-support-base-for-solaci/" title="Read more" >...</a>